The Effects of Hypertension and Stroke on the Cerebral Vasculature

2016 ◽  
pp. 81-108 ◽  
Author(s):  
Anne M. Dorrance
Keyword(s):  
2021 ◽  
pp. 107385842110122
Author(s):  
Tamara L. Baker ◽  
Denes V. Agoston ◽  
Rhys D. Brady ◽  
Brendan Major ◽  
Stuart J. McDonald ◽  
...  

The diagnosis, prognosis, and treatment of mild traumatic brain injuries (mTBIs), such as concussions, are significant unmet medical issues. The kinetic forces that occur in mTBI adversely affect the cerebral vasculature, making cerebrovascular injury (CVI) a pathophysiological hallmark of mTBI. Given the importance of a healthy cerebrovascular system in overall brain function, CVI is likely to contribute to neurological dysfunction after mTBI. As such, CVI and related pathomechanisms may provide objective biomarkers and therapeutic targets to improve the clinical management and outcomes of mTBI. Despite this potential, until recently, few studies have focused on the cerebral vasculature in this context. This article will begin by providing a brief overview of the cerebrovascular system followed by a review of the literature regarding how mTBI can affect the integrity and function of the cerebrovascular system, and how this may ultimately contribute to neurological dysfunction and neurodegenerative conditions. We then discuss promising avenues of research related to mTBI biomarkers and interventions that target CVI, and conclude that a clinical approach that takes CVI into account could result in substantial improvements in the care and outcomes of patients with mTBI.


2021 ◽  
Vol 30 ◽  
pp. 102573
Author(s):  
Aditi Deshpande ◽  
Nima Jamilpour ◽  
Bin Jiang ◽  
Patrik Michel ◽  
Ashraf Eskandari ◽  
...  

2012 ◽  
Vol 590 (24) ◽  
pp. 6343-6352 ◽  
Author(s):  
J. W. Hamner ◽  
Can Ozan Tan ◽  
Yu-Chieh Tzeng ◽  
J. Andrew Taylor
Keyword(s):  

2016 ◽  
Vol 410 (2) ◽  
pp. 190-201 ◽  
Author(s):  
Ujala Rana ◽  
Zhong Liu ◽  
Suresh N. Kumar ◽  
Baofeng Zhao ◽  
Wenquan Hu ◽  
...  

2014 ◽  
Vol 81 (3-4) ◽  
pp. 490-491 ◽  
Author(s):  
Joshua Lucas ◽  
William J. Mack

2001 ◽  
Author(s):  
William J. Calvo ◽  
Baruch B. Lieber ◽  
Ajay K. Wakhloo ◽  
L. Nelson Hopkins

Abstract Use of embolic agents is currently an accepted treatment modality among neurointerventional clinicians in order to completely occlude abnormal shunts in the cerebral vasculature known as arteriovenous malformations or AVMs. The first cyanoacrylate polymer recently approved by the US Food and Drug Administration for use in humans is n-butyl 2-cyanoacrylate (NBCA). In order to control the polymerization time of NBCA, as well as to opacify the mixture for angiographic visualization, an iodized poppyseed oil-based contrast agent (Lipiodol) is added to the NBCA. Glacial acetic acid is also used to delay polymerization further by decreasing the pH of the mixture.


Neurosurgery ◽  
2000 ◽  
Vol 46 (1) ◽  
pp. 138-151 ◽  
Author(s):  
Michael M. O'Connor ◽  
Marc R. Mayberg

2001 ◽  
Vol 1 ◽  
pp. 5-5 ◽  
Author(s):  
A. F. Russo ◽  
P. L. Durham

The neuropeptide calcitonin gene-related peptide (CGRP) is a potent regulator of cerebral vascular tone and contributes to neurogenic inflammation. Clinical studies have shown that CGRP levels are elevated during the painful phase of migraine headache, then restored to baseline by antimigraine 5-HT1 drugs. Conversely, CGRP is depleted in perivascular nerve terminals from patients who have suffered vasospasm following subarachnoid hemorrhage. We have investigated the mechanisms controlling CGRP expression in the trigeminal ganglia neurons, which provide virtually all of the CGRP innervation to the cerebral vasculature. We found that nerve depolarization, inflammatory compounds, and nitric oxide can increase CGRP synthesis and secretion. Using both adenoviral vectors and transfection approaches, we have shown that the increased synthesis is due to activation of a cell-specific MAP kinase-responsive enhancer upstream of the CGRP gene. Interestingly, the 5-HT1 migraine drugs are able to block this up-regulation by a mechanism that involves a very prolonged elevation of calcium. We have shown that the duration of the calcium signal is a key determinant for whether a MAP kinase responsive gene will be stimulated or repressed by calcium-activated pathways. This observation supports the importance of a finely tuned balance of calcium in the trigeminal neuron, which is intriguing in light of genetic evidence for calcium channel mutations in a rare form of inherited migraine. These studies suggest that modulation of MAP kinase control of the cell-specific CGRP gene enhancer may be a useful therapeutic strategy for neurovascular disorders.


2003 ◽  
Vol 284 (1) ◽  
pp. E184-E192 ◽  
Author(s):  
Chris Stirone ◽  
Sue P. Duckles ◽  
Diana N. Krause

The cerebral vasculature is an important target tissue for estrogen, as evidenced by significant effects of estrogen on vascular reactivity and protein levels of endothelial nitric oxide synthase and prostacyclin synthase. However, the presence, localization, and regulation of estrogen receptors in the cerebral vasculature have not been investigated. In this study, we identified the presence of estrogen receptor-α (ER-α) in female rat cerebral blood vessels and localized this receptor to both smooth muscle and endothelial cells by use of immunohistochemistry and confocal microscopy. With immunoblot analysis, multiple forms of ER-α were detected at 110, 93, 82, 50, and 45 kDa in addition to a relatively weak band corresponding to the 66-kDa putative unmodified receptor. The 82-kDa band was identified as Ser118-phosphorylated ER-α, whereas the 50-kDa band lacks the normal NH2 terminus, suggestive of an ER-α splice variant. Lower molecular mass bands persisted after in vivo inhibition of 26S proteasome activity with lactacystin, whereas the 110- and 93-kDa bands increased. All forms of ER-α in cerebral vessels were decreased after ovariectomy but significantly increased after chronic estrogen exposure in vivo.


Sign in / Sign up

Export Citation Format

Share Document